This option is made likely by the results of some of the studies mentioned above, although more detailed tests using animal model systems are not available and the real efficacy of these agents in maintaining/expanding the CLL clone independently of BcR stimulation remains to be determined. Here, BCR is linked to B-cell chronic lymphocytic leukemia.